Nanoparticles of spinel and perovskite ferromagnets and prospects for their application in medicine

被引:10
作者
Belous, A. G. [1 ]
Solopan, S. O. [1 ]
Yelenich, O. V. [1 ]
Tovstolytkin, A. I. [2 ]
Kolodiazhnyi, T. V. [3 ]
Osinsky, S. P. [4 ]
Bubnovskaya, L. N. [4 ]
机构
[1] Inst Gen & Inorgan Chem, Prospekt Palladina 32-34, UA-03142 Kiev, Ukraine
[2] Inst Magnetism, UA-03142 Kiev, Ukraine
[3] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan
[4] RF Kavetsky Inst Expt Pathol Oncol & Radiobiol, UA-03022 Kiev, Ukraine
来源
ELECTROCERAMICS XIV CONFERENCE | 2014年 / 1627卷
关键词
MAGNETIC FLUID; HYPERTHERMIA; MEDIATORS; THERAPY;
D O I
10.1063/1.4901650
中图分类号
TQ174 [陶瓷工业]; TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
In this work, nanoparticles of La0.75Sr0.25MnO3 compounds with perovskite structure and AFe(2)O(4) (A = Mn, Fe, Co, Ni, Zn) with spinel structure have been synthesized by precipitation from diethylene glycol and microemulsion using Triton X-100 surfactant. Comparative X-ray diffraction and magnetic studies of the synthesized nanoparticles have been carried out. Magnetic fluids prepared from synthesized nanopowders have been characterized by calorimetric measurements of specific loss power (SLP).
引用
收藏
页码:13 / 18
页数:6
相关论文
共 20 条
[1]  
Andra W., 1998, Magnetism in medicine, P455
[2]  
Belous A., ELECT NANOTECHNOLOGY, P280
[3]   Effects of chemical composition and sintering temperature on the structure of La1-xSrxMnO3±γ solid solutions [J].
Belous, AG ;
V'yunov, OI ;
Pashkova, EV ;
Yanchevskii, OZ ;
Tovstolytkin, AI ;
Pogorelyi, AM .
INORGANIC MATERIALS, 2003, 39 (02) :161-170
[4]   Synthesis, magnetic properties, surface modification and cytotoxicity evaluation of Y3Fe5-xAlxO12 (0 ≤ x ≤ 2) garnet submicron particles for biomedical applications [J].
Grasset, F ;
Mornet, S ;
Demourgues, A ;
Portier, J ;
Bonnet, J ;
Vekris, A ;
Duguet, E .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2001, 234 (03) :409-418
[5]   Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia [J].
Jordan, A ;
Scholz, R ;
Maier-Hauff, K ;
Johannsen, M ;
Wust, P ;
Nadobny, J ;
Schirra, H ;
Schmidt, H ;
Deger, S ;
Loening, S ;
Lanksch, W ;
Felix, R .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2001, 225 (1-2) :118-126
[6]   Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery [J].
Kumar, Challa S. S. R. ;
Mohammad, Faruq .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (09) :789-808
[7]  
Kumar P., 1999, HDB MICROEMULSION SC, P864
[8]  
Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]
[9]   Magnetic nanoparticle design for medical diagnosis and therapy [J].
Mornet, S ;
Vasseur, S ;
Grasset, F ;
Duguet, E .
JOURNAL OF MATERIALS CHEMISTRY, 2004, 14 (14) :2161-2175
[10]   Magnetically mediated hyperthermia: current status and future directions [J].
Moroz, P ;
Jones, SK ;
Gray, BN .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2002, 18 (04) :267-284